Radiotherapy for Non-Malignant Disorders

Cover
Michael Heinrich Seegenschmiedt, Hans-Bruno Makoski, Klaus-Rüdiger Trott, Luther W. Brady
Springer Science & Business Media, 15.04.2009 - 748 Seiten
0 Rezensionen
Non-malignant, or "benign", diseases can be successfully treated using ionizing rad- tion technologies. It was first proposed in 1898 by Sokoloff, who reported the analgesic effects of radiotherapy for painful rheumatoid arthritis. Since then, the use of these techniques for painful muscle-skeletal diseases has gained acceptance particularly in Europe but is still carried out actively in the United States. Non-malignant diseases that are amenable to radiotherapy can be classified as inflammatory, degenerative, hype- roliferative, functional, or other disorders. However, the topographic and morphologic considerations are more relevant. Even though radiation therapy for "benign" diseases has not been pursued actively since the 1950s, more recent interest has dictated that it can be a very effective treatment modality. The use of radiotherapy can be justified for invasive and aggressive growth such as that seen with desmoids, for cosmetic d- figurations and functional loss as seen with keloids or endocrine orbitopathy, or for life-threatening complications such as hepatic hemangiomas or juvenile angiofibromas that occur in children or adolescents. Many of the non-malignant diseases can have a major and lasting effect on quality of life by causing pain or other serious symptoms, particularly when other methods of treatment are unavailable, have failed, or may induce more side effects. It is not generally the first choice of therapy in these non-malignant diseases, but it is acceptable as defined. The book edited by Seegenschmiedt et al.
 

Was andere dazu sagen - Rezension schreiben

Es wurden keine Rezensionen gefunden.

Inhalt

Radiobiological Principles
17
K R Trott MD tion restenosis or keloids or of progression
29
Side Effects and LongTerm Risks from Radiotherapy of Benign Diseases
41
Risk Assessment and Carcinogenesis Modelling
49
Radiophysical Principles
69
Clinical Principles
97
A Survey
131
Skin and Soft Tissue Disorders
145
Vertebral Hemangiomas SVH
426
Aneurysmal Bone Cyst ABC
447
P Schueller S Hesselmann and 0 Micke 459
462
Aggressive FibromatosisDesmoid Tumors
480
Pterygium
505
Hemangiomas and Vascular Tumors of the
513
Furunculitis Hidradenitis Panaritium and Paronychia
525
Lymphocutaneous Fistulas and Lymphoceles
545

Tumors Hyperplasia Dermatoses
153
Peyronies Disease
192
Keloids and Hypertrophic Scars
215
Orthopaedic Examination Tests and Clinical Scores
243
Rotator Cuff Syndrome RCS
261
Humeral Epicondylopathia HEP Lateral and Medial Humeral Epicondylitis
280
Plantar and Dorsal Heel SpurHeel Spur Syndrome
307
F H Kamprad MD benign tumours such as fibromas Doses are
317
General Survey for All Sites
335
Heterotopic Ossification Prophylaxis The
369
Pigmented Villonodular Synovitis PVNS
395
Langerhans Cell Histiocytosis LCH
411
Head and Neck
563
NonMalignant Disorders of the Head Region
569
CNS and Brain
581
ArterioVenous Malformation
605
Vestibular Schwannoma Acoustic Neuroma
629
Pituitary Adenoma
653
Trigeminal Neuralgia
675
Pseudotumor Orbitae
710
Registry for Rare Benign Diseases
721
List of Contributors
737
Urheberrecht

Andere Ausgaben - Alle anzeigen

Häufige Begriffe und Wortgruppen

Bibliografische Informationen